Financials
Income statement
Fiscal date | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 |
---|---|---|---|---|
Total reported revenue | 2.6T | 2.4T | 2.5T | 2.3T |
Cost of revenue | 1.6T | 1.5T | 1.6T | 1.5T |
Gross profit | 942.6B | 900.7B | 947.3B | 853.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 50.8B | 47.8B | 108.0B | 25.2B |
Non operating interest income | ||||
Income | 1.3B | 1.4B | 1.6B | 1.3B |
Expense | 10.8B | 10.1B | 10.0B | 10.0B |
Other income expense | — | — | — | — |
Pretax income | 37.0B | 40.1B | 64.1B | 21.9B |
Tax provision | 24.4B | 21.8B | 17.4B | 18.4B |
Net income | 12.6B | 18.3B | 46.7B | 3.5B |
Basic EPS | — | 6.0 | — | — |
Diluted EPS | — | 6.0 | — | — |
Basic average shares | — | 856.0M | — | — |
Diluted average shares | — | 857.0M | — | — |
EBITDA | 55.2B | 55.5B | 113.8B | 31.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | -12.3B | -13.2B | -20.3B | -8.5B |
Preferred stock dividends | 0 | 0 | 0 | 0 |